160 related articles for article (PubMed ID: 11323101)
1. Significance of MDR1, MRP1, GSTpi and GSTmu mRNA expression in acute lymphoblastic leukemia in Indian patients.
Gurbuxani S; Singh Arya L; Raina V; Sazawal S; Khattar A; Magrath I; Marie J; Bhargava M
Cancer Lett; 2001 Jun; 167(1):73-83. PubMed ID: 11323101
[TBL] [Abstract][Full Text] [Related]
2. Expression of genes implicated in multidrug resistance in acute lymphoblastic leukemia in India.
Gurbuxani S; Zhou D; Simonin G; Raina V; Arya LS; Sazawal S; Marie JP; Bhargava M
Ann Hematol; 1998 May; 76(5):195-200. PubMed ID: 9671132
[TBL] [Abstract][Full Text] [Related]
3. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
Do JH; Oh SH; Song EJ; Chung JS; Kang CD; Lee EY
Korean J Lab Med; 2007 Aug; 27(4):229-36. PubMed ID: 18094581
[TBL] [Abstract][Full Text] [Related]
4. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
[TBL] [Abstract][Full Text] [Related]
5. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
Leith CP; Kopecky KJ; Chen IM; Eijdems L; Slovak ML; McConnell TS; Head DR; Weick J; Grever MR; Appelbaum FR; Willman CL
Blood; 1999 Aug; 94(3):1086-99. PubMed ID: 10419902
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia.
Ogretmen B; Barredo JC; Safa AR
J Pediatr Hematol Oncol; 2000; 22(1):45-9. PubMed ID: 10695821
[TBL] [Abstract][Full Text] [Related]
7. Expression of multidrug resistance-related transporters in human breast carcinoma.
Kanzaki A; Toi M; Nakayama K; Bando H; Mutoh M; Uchida T; Fukumoto M; Takebayashi Y
Jpn J Cancer Res; 2001 Apr; 92(4):452-8. PubMed ID: 11346468
[TBL] [Abstract][Full Text] [Related]
8. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance-associated protein 1 predicts relapse in Iranian childhood acute lymphoblastic leukemia.
Mahjoubi F; Akbari S
Asian Pac J Cancer Prev; 2012; 13(5):2285-9. PubMed ID: 22901208
[TBL] [Abstract][Full Text] [Related]
10. Analysis of MDR1 and MDR3 multidrug resistance gene expression and amplification in consecutive samples in patients with acute leukaemias.
MacFarland A; Dawson AA; Pearson CK
Leuk Lymphoma; 1995 Sep; 19(1-2):135-40. PubMed ID: 8574159
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia.
Fujimaki S; Funato T; Harigae H; Fujiwara J; Kameoka J; Meguro K; Kaku M; Sasaki T
Clin Chem; 2002 Jun; 48(6 Pt 1):811-7. PubMed ID: 12028995
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.
Casale F; D'Angelo V; Addeo R; Caraglia M; Crisci S; Rondelli R; Di Tullio MT; Indolfi P
Oncol Rep; 2004 Dec; 12(6):1201-7. PubMed ID: 15547738
[TBL] [Abstract][Full Text] [Related]
15. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
[TBL] [Abstract][Full Text] [Related]
16. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
Farawela HM; Khorshied MM; Kassem NM; Kassem HA; Zawam HM
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1323-30. PubMed ID: 24804815
[TBL] [Abstract][Full Text] [Related]
17. The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance.
O'Brien M; Kruh GD; Tew KD
J Pharmacol Exp Ther; 2000 Aug; 294(2):480-7. PubMed ID: 10900222
[TBL] [Abstract][Full Text] [Related]
18. GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia.
Stanulla M; Schäffeler E; Arens S; Rathmann A; Schrauder A; Welte K; Eichelbaum M; Zanger UM; Schrappe M; Schwab M
Int J Hematol; 2005 Jan; 81(1):39-44. PubMed ID: 15717687
[TBL] [Abstract][Full Text] [Related]
19. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
[TBL] [Abstract][Full Text] [Related]
20. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
